Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Mar 2000

Harima Y, Harima K, Sawada S, Tanaka Y, Arita S, Ohnishi T

Abstract excerpt

Cervical carcinomas develop as a result of multiple genetic alterations, and specific alterations lead to specific clinical behavior. However, the effect of such alterations on the recurrence of cervical cancer after radiotherapy remains unknown. Chromosome arm 6p is one of those most frequently involved in a loss of heterozygosity (LOH) in patients with cervical carcinoma. The aim of this study was to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 6
Share to Loss of Heterozygosity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Papillomaviridae

Share to Papillomavirus Infections

Share to Survival Analysis

Share to Tumor Virus Infections

Share to Uterine Cervical Neoplasms

Source

Identifiers

PMID: 10741737

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.PMID 10741737Read ↗

Chromosome 6p21.2, 18q21.2 and human papilloma virus (HPV) DNA can predict prognosis of cervical cancer after radiotherapy.Semantic proximity Read ↗

Cervical intraepithelial neoplasia III shows frequent allelic loss in 3p and 6p.Semantic proximity Read ↗

Loss of heterozygosity of D9S162: molecular predictor for treatment response in oral carcinoma.Semantic proximity Read ↗

Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study.Semantic proximity Read ↗

Genetic alterations on chromosome 17p associated with response to radiotherapy in bulky cervical cancer.Semantic proximity Read ↗

Analysis of H-ras Mutations and Immunohistochemistry in Recurrence Cases of High-Grade Oral Squamous Cell Carcinoma.Semantic proximity Read ↗

Protein expression of p53 and Bcl-2 has a strong correlation with radiation resistance of laryngeal squamous cell carcinoma but does not predict the radiation failure before treatment.Semantic proximity Read ↗

Association of Preoperative Cone Biopsy With Recurrences After Radical HysterectomySemantic proximity Read ↗

Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary?Semantic proximity Read ↗

p53 mutations are rare events in recurrent cervical cancer.Semantic proximity Read ↗

9p21 deletion correlates with recurrence in head and neck cancerSemantic proximity Read ↗

Association Between Recurrence of Sporadic Colorectal Cancer, High Level of Microsatellite Instability, and Loss of Heterozygosity at Chromosome 18qSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.